severeasthma@newcastle.edu.au

Publication List

Home Research Publication List

Research published by Centre of Excellence in Severe Asthma investigators is highlighted below, focused on publications that are directly relevant to asthma broadly, and severe asthma in particular.

2019 Publications (Updated 03 October 2019)
2018 Publications
2017 Publications
2016 Publications
2015 Publications
2019 Publications (Updated 03 October 2019)
  1. Hiles SA, McDonald VM, Guilhermino M, Brusselle G, Gibson PG. (2019) Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis. Eur Respir J. Accepted.
  2. Holguin F, Cardet C, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, Gaga M, Kellermeyer L, Khurana S, Knight S, McDonald VM, Morgan R, Ortega V, Rigau D, Subbarao P, Tonia T, Adcock IM, Bleecker E, Brightling C, Boulet LP, Cabana M, Castro M, Chanez P, Custovic A, Djukanovic R, Frey U, Frankemolle B, Gibson PG, Hamerlijnck D, Jarjour N, Konno S, Shen H, Vitary C, Bush A.(2019) Management of Severe Asthma: a European Respiratory Society/American Thoracic Society Guideline. . Eur Respir J. Accepted.
  3. Majellano E, Clark VL, Winter NA, Gibson PG, McDonald VM.(2019) Assessment of Severe Asthma in Adults: Barriers and Approaches. J Asthma Allergy. Accepted.
  4. Zhang L, Zhang X, Zheng J, Liu Y, Wang J, Wang G, Zhang HP, Kang DY, Peng ZG, Ji YL, Wang L, Gibson PG, Wang G.(2019) Depressive symptom-associated IL-1β and TNF-α release correlates with impaired bronchodilator response and neutrophilic airway inflammation in asthma. Clinical and Experimental Allergy.49(6):770-80.
  5. Wood LG, Li Q, Scott HA, Rutting S, Berthon BS, Gibson PG, Hansbro PM, Williams E, Horvat J, Simpson JL, Young P, Oliver BG, Baines KJ.(2019) Saturated fatty acids, obesity, and the nucleotide oligomerization domain–like receptor protein 3 (NLRP3) inflammasome in asthmatic patients. Journal of Allergy and Clinical Immunology.143(1):305-15.
  6. Wong A, Hardaker K, Field P, Huvanandana J, King GG, Reddel H, Selvadurai H, Thamrin C, Robinson PD.(2019) Home-based forced Oscillation technique day-to-day variability in Pediatric Asthma. American Journal of Respiratory and Critical Care Medicine.199(9):1156-60.
  7. Whalen OM, Campbell LE, Murphy VE, Lane AE, Gibson PG, Mattes J, Collison A, Mallise CA, Woolard A, Karayanidis F.(2019) Observational study of mental health in asthmatic women during the prenatal and postnatal periods. Journal of Asthma.
  8. Wang H, FitzPatrick M, Wilson NJ, Anthony D, Reading PC, Satzke C, Dunne EM, Licciardi PV, Seow HJ, Nichol K, Adcock IM, Chung KF, Anderson GP, Vlahos R, Wark P, Bozinovski S.(2019) CSF3R/CD114 mediates infection-dependent transition to severe asthma. J Allergy Clin Immunol.143(2):785-8 e6.
  9. Upham JW.(2019) Contemporary Concise Review 2018: Asthma and chronic obstructive pulmonary disease. Respirology.24(7):693-9.
  10. Tudball J, Reddel HK, Laba TL, Jan S, Flynn A, Goldman M, Lembke K, Roughead E, Marks GB, Zwar N.(2019) General practitioners’ views on the influence of cost on the prescribing of asthma preventer medicines: A qualitative study. Australian Health Review.43(3):246-53.
  11. Tonga KO, Berend N, Thamrin C, Farah CS, Jetmalani K, Chapman DG, King GG.(2019) Lung elastic recoil and ventilation heterogeneity of diffusion-dependent airways in older people with asthma and fixed airflow obstruction. The European respiratory journal.53(3).
  12. Thompson B.(2019) The patients are the ones missing out: A desperate need to standardize lung function reference equations. Respirology.
  13. Taylor SL, Leong LEX, Mobegi FM, Choo JM, Wesselingh S, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Baraket M, Marks GB, Gibson PG, Rogers GB, Simpson JL.(2019) Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma. Am J Respir Crit Care Med.200(3):309-17.
  14. Stubbs M, Clark VL, McDonald VM.(2019) Living well with severe asthma. Breathe.15(2).
  15. Simpson AJ, Hekking PP, Shaw DE, Fleming LJ, Roberts G, Riley JH, Bates S, Sousa AR, Bansal AT, Pandis I, Sun K, Bakke PS, Caruso M, Dahlén B, Dahlén SE, Horvath I, Krug N, Montuschi P, Sandstrom T, Singer F, Adcock IM, Wagers SS, Djukanovic R, Chung KF, Sterk PJ, Fowler SJ, Ahmed H, Auffray C, Baribaud F, Bel EH, Bigler J, Bisgaard H, Boedigheimer MJ, Bønnelykke K, Brandsma J, Brinkman P, Bucchioni E, Burg D, Bush A, Chaiboonchoe A, Chanez P, Compton CH, Corfield J, D’Amico A, De Meulder B, Erpenbeck VJ, Erzen D, Fichtner K, Fitch N, Fleming LJ, Formaggio E, Frey U, Gahlemann M, Geiser T, Goss V, Guo Y, Hashimoto S, Haughney J, Hedlin G, Hekking PW, Higenbottam T, Hohlfeld JM, Holweg C, Horváth I, Howarth P, James AJ, Knowles R, Knox AJ, Lefaudeux D, Loza MJ, Lutter R, Manta A, Masefield S, Matthews JG, Mazein A, Meiser A, Middelveld RJM, Miralpeix M, Mores N, Murray CS, Musial J, Myles D, Pahus L, Pavlidis S, Postle A, Powel P, Praticò G, Puig Valls M, Rao N, Roberts A, Roberts G, Rowe A, Sandström T, Schofield JPR, Seibold W, Selby A, Sigmund R, Skipp PJ, Thornton B, van Aalderen WM, van Geest M, Vestbo J, Vissing NH, Wagener AH, Weiszhart Z, Wheelock CE, Wilson SJ.(2019) Treatable traits in the European U-BIOPRED adult asthma cohorts. Allergy: European Journal of Allergy and Clinical Immunology.74(2):406-11.
  16. Senaratna CV, Walters EH, Hamilton G, Lowe AJ, Lodge C, Burgess J, Erbas B, Giles GG, Thomas P, Abramson MJ, Thompson B, Perret JL, Dharmage SC.(2019) Nocturnal symptoms perceived as asthma are associated with obstructive sleep apnoea risk, but not bronchial hyper-reactivity. Respirology.
  17. Schofield JPR, Burg D, Nicholas B, Strazzeri F, Brandsma J, Staykova D, Folisi C, Bansal AT, Xian Y, Guo Y, Rowe A, Corfield J, Wilson S, Ward J, Lutter R, Shaw DE, Bakke PS, Caruso M, Dahlen SE, Fowler SJ, Horváth I, Howarth P, Krug N, Montuschi P, Sanak M, Sandström T, Sun K, Pandis I, Riley J, Auffray C, De Meulder B, Lefaudeux D, Sousa AR, Adcock IM, Chung KF, Sterk PJ, Skipp PJ, Djukanović R, Ahmed H, Allen D, Badorrek P, Ballereau S, Baribaud F, Bedding A, Behndig AF, Berglind A, Berton A, Bigler J, Boedigheimer MJ, Bønnelykke K, Brinkman P, Bush A, Campagna D, Casaulta C, Chaiboonchoe A, Davison T, De Meulder B, Delin I, Dennison P, Dodson P, El Hadjam L, Erzen D, Faulenbach C, Fichtner K, Fitch N, Formaggio E, Gahlemann M, Galffy G, Garissi D, Garret T, Gent J, Guillmant-Farry E, Henriksson E, Hoda U, Hohlfeld JM, Hu X, James A, Johnson K, Jullian N, Kerry G, Klüglich M, Knowles R, Konradsen JR, Kretsos K, Krueger L, Lantz AS, Larminie C, Latzin P, Lefaudeux D, Lemonnier N, Lowe LA, Lutter R, Manta A, Mazein A, McEvoy L, Menzies-Gow A, Mores N, Murray CS, Nething K, Nihlén U, Niven R, Nordlund B, Nsubuga S, Pellet J, Pison C, Praticò G, Valls MP, Riemann K, Rocha JP, Rossios C, Santini G, Saqi M, Scott S, Sehgal N, Selby A, Söderman P, Sogbesan A, Spycher F, Stephan S, Stokholm J, Sunther M, Szentkereszty M, Tamasi L, Tariq K, Valente S, van Aalderen WM, van Drunen CM, Van Eyll J, Vyas A, Yu W, Zetterquist W, Zolkipli Z, Zwinderman AH.(2019) Stratification of asthma phenotypes by airway proteomic signatures. Journal of Allergy and Clinical Immunology.144(1):70-82.
  18. Robijn AL, Murphy VE, Gibson PG.(2019) Recent developments in asthma in pregnancy. Current opinion in pulmonary medicine.25(1):11-7.
  19. Robijn AL, Jensen ME, Gibson PG, Powell H, Giles WB, Clifton VL, Mattes J, Peek MJ, Barrett HL, Seeho SK, Callaway LK, Abbott A, Attia J, Wark PA, Murphy VE.(2019) Trends in asthma self-management skills and inhaled corticosteroid use during pregnancy and postpartum from 2004 to 2017. Journal of Asthma.56(6):594-602.
  20. Revez JA, Bain LM, Watson RM, Towers M, Collins T, Killian KJ, O’Byrne PM, Gauvreau GM, Upham JW, Ferreira MAR.(2019) Effects of interleukin-6 receptor blockade on allergen-induced airway responses in mild asthmatics. Clinical and Translational Immunology.8(6).
  21. Reddel HK, FitzGerald JM, Bateman ED, Bacharier LB, Becker A, Brusselle G, Buhl R, Cruz AA, Fleming L, Inoue H, Ko FWS, Krishnan JA, Levy ML, Lin J, Pedersen SE, Sheikh A, Yorgancioglu A, Boulet LP.(2019) GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents. The European respiratory journal.53(6).
  22. Qin L, Gibson PG, Simpson JL, Baines KJ, McDonald VM, Wood LG, Powell H, Fricker M.(2019) Dysregulation of sputum columnar epithelial cells and products in distinct asthma phenotypes. Clin Exp Allergy.0(ja).
  23. Pang Z, Wang G, Gibson P, Guan X, Zhang W, Zheng R, Chen F, Wang Z, Wang F.(2019) Airway microbiome in different inflammatory phenotypes of asthma: A cross-sectional study in northeast China. International Journal of Medical Sciences.16(3):477-85.
  24. Nilsen K, Thien F, Thamrin C, Ellis MJ, Kim Prisk G, King GG, Thompson B(2019) Early onset of airway derecruitment assessed using the forced oscillation technique in subjects with asthma. Journal of Applied Physiology.126(5):1399-408.
  25. Narla SP, Upham JW. Immunity to Rhinovirus. Rhinovirus Infections: Rethinking the impact on human health and disease: Elsevier; 2019.
  26. Mogensen I, Alving K, Dahlen SE, James A, Forsberg B, Ono J, Ohta S, Venge P, Borres MP, Izuhara K, Janson C, Malinovschi A.(2019) Fixed airflow obstruction relates to eosinophil activation in asthmatics. Clinical and Experimental Allergy.49(2):155-62.
  27. McLoughlin R, Berthon BS, Rogers GB, Baines KJ, Leong LEX, Gibson PG, Williams EJ, Wood LG.(2019) Soluble fibre supplementation with and without a probiotic in adults with asthma: A 7-day randomised, double blind, three way cross-over trial. EBioMedicine.
  28. McDonald VM, Osadnik CR, Gibson PG.(2019) Treatable traits in acute exacerbations of chronic airway diseases. Chron Respir Dis.16:1479973119867954.
  29. McDonald VM, Kennington E, Hyland M. Understanding the experience of people living with severe asthma. In: Chung KF, Israel E, Gibson PG, editors. Severe Asthma (ERS Monograph): European Respiratory Society; 2019. p. 16-29.
  30. McDonald VM, Hiles SA, Godbout K, Harvey ES, Marks GB, Hew M, Peters M, Bardin PG, Reynolds PN, Upham JW, Baraket M, Bhikoo Z, Bowden J, Brockway B, Chung LP, Cochrane B, Foxley G, Garrett J, Jayaram L, Jenkins C, Katelaris C, Katsoulotos G, Koh MS, Kritikos V, Lambert M, Langton D, Lara Rivero A, Middleton PG, Nanguzgambo A, Radhakrishna N, Reddel H, Rimmer J, Southcott AM, Sutherland M, Thien F, Wark PAB, Yang IA, Yap E, Gibson PG.(2019) Treatable traits can be identified in a severe asthma registry and predict future exacerbations. Respirology.24(1):37-47.
  31. McDonald VM, Gibson PG.(2019) Treatable traits and their application in high-, middle- and low-income countries. Respirology.
  32. McDonald VM, Fingleton J, Agusti A, Hiles SA, Clark VL, Holland AE, Marks GB, Bardin PP, Beasley R, Pavord ID, Wark PAB, Gibson PG, Agusti A, Anderson G, Bardin PP, Beasley R, Cheng A, Chung LP, Clark VL, Dabscheck E, Dharmage S, Fingleton J, Gibson P, Hardy J, Hew M, Hiles SA, Holland AE, James A, Lam K, Jayaram L, Katelaris C, Leong P, MacDonald M, Mangan N, Marks GB, McDonald C, McDonald VM, Morgan L, Osadnik C, Pavord ID, Plank M, Roberts M, Searles A, See H, Spencer A, Upham J, Wark PAB.(2019) Treatable traits: A new paradigm for 21st century management of chronic airway diseases: Treatable Traits down under International Workshop report. European Respiratory Journal.53(5).
  33. Lokwani R, Wark PAB, Baines KJ, Barker D, Simpson JL.(2019) Hypersegmented airway neutrophils and its association with reduced lung function in adults with obstructive airway disease: An exploratory study. BMJ Open.9(1).
  34. Liu G, Mateer SW, Hsu A, Goggins BJ, Tay H, Mathe A, Fan K, Neal R, Bruce J, Burns G, Minahan K, Maltby S, Fricker M, Foster PS, Wark PAB, Hansbro PM, Keely S.(2019) Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome. Mucosal Immunology.
  35. Laba TL, Reddel HK, Zwar NJ, Marks GB, Roughead E, Flynn A, Goldman M, Heaney A, Lembke K, Jan S.(2019) Does a Patient-Directed Financial Incentive Affect Patient Choices About Controller Medicines for Asthma? A Discrete Choice Experiment and Financial Impact Analysis. PharmacoEconomics.37(2):227-38.
  36. Laba TL, Jan S, Zwar NA, Roughead E, Marks GB, Flynn AW, Goldman MD, Heaney A, Lembke KA, Reddel HK.(2019) Cost-Related Underuse of Medicines for Asthma—Opportunities for Improving Adherence. Journal of Allergy and Clinical Immunology: In Practice.
  37. Kneale D, Harris K, McDonald VM, Thomas J, Grigg J.(2019) Effectiveness of school-based self-management interventions for asthma among children and adolescents: findings from a Cochrane systematic review and meta-analysis. Thorax.
  38. King GG, Thamrin C.(2019) Obesity and the lungs: Not just a crush. Respirology.24(6):502-3.
  39. King GG, Farrow CE, Chapman DG.(2019) Dismantling the pathophysiology of asthma using imaging. European Respiratory Review.28(152).
  40. Khatri S, Moore W, Gibson PG, Leigh R, Bourdin A, Maspero J, Barros M, Buhl R, Howarth P, Albers FC, Bradford ES, Gilson M, Price RG, Yancey SW, Ortega H.(2019) Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma. Journal of Allergy and Clinical Immunology.143(5):1742-51.e7.
  41. Jones KA, Gibson PG, Yorke J, Niven R, Smith A, McDonald VM.(2019) Attack, Flare-up or Exacerbation? The terminology preferences of patients with severe asthma. J Asthma.1-15.
  42. Jensen ME, Murphy VE, Gibson PG, Mattes J, Camargo CA.(2019) Vitamin D status in pregnant women with asthma and its association with adverse respiratory outcomes during infancy. Journal of Maternal-Fetal and Neonatal Medicine.32(11):1820-5.
  43. Holt NR, Thompson BR, Miller B, Borg BM.(2019) Substantial variation exists in spirometry interpretation practices for airflow obstruction in accredited lung function laboratories across Australia and New Zealand. Intern Med J.49(1):41-7.
  44. Harris K, Kneale D, Lasserson TJ, McDonald VM, Grigg J, Thomas J.(2019) School-based self-management interventions for asthma in children and adolescents: a mixed methods systematic review. Cochrane Database Syst Rev.1(1):CD011651.
  45. Hains I, Meyers J, Sterling K, Yoo J, Reddel H, Weston C.(2019) Difficult-to-treat and severe asthma in general practice: Delivery and evaluation of an educational program. BMC Family Practice.20(1).
  46. Gong T, Lundholm C, Rejnö G, Bölte S, Larsson H, D’Onofrio BM, Lichtenstein P, Almqvist C.(2019) Parental asthma and risk of autism spectrum disorder in offspring: A population and family-based case-control study. Clinical and Experimental Allergy.
  47. Gibson PG.(2019) Maternal history of miscarriages and measures of fertility in relation to childhood asthma. Thorax.74(2):101-2.
  48. Fricker M, Gibson PG, Powell H, Simpson JL, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Baines KJ.(2019) A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma. Journal of Allergy and Clinical Immunology.144(1):51-60.e11.
  49. Farrow C, King G.(2019) SPECT Ventilation Imaging in Asthma. Semin Nucl Med.49(1):11-5.
  50. Farah CS, Badal T, Reed N, Rogers PG, King GG, Thamrin C, Peters MJ, Seccombe LM.(2019) Mepolizumab improves small airway function in severe eosinophilic asthma. Respiratory Medicine.148:49-53.
  51. Erriah M, Pabreja K, Fricker M, Baines KJ, Donnelly LE, Bylund J, Karlsson A, Simpson JL.(2019) Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma. Respiratory Research.20(1).
  52. Eassey D, Reddel HK, Ryan K, Smith L.(2019) The impact of severe asthma on patients’ autonomy: A qualitative study. Health Expectations.22(3):528-36.
  53. Eassey D, Reddel HK, Foster JM, Kirkpatrick S, Locock L, Ryan K, Smith L.(2019) “…I’ve said I wish I was dead, you’d be better off without me”: A systematic review of people’s experiences of living with severe asthma. Journal of Asthma.56(3):311-22.
  54. Duszyk K, Gibson PG, McDonald VM.(2019) Mechanisms underlying fixed airflow obstruction and exacerbations. Eur Resp Monogr.84:82-92.
  55. Denton E, Hore-Lacy F, Radhakrishna N, Gilbert A, Tay T, Lee J, Dabscheck E, Harvey ES, Bulathsinhala L, Fingleton J, Price D, Gibson PG, O’Hehir R, Hew M.(2019) Severe Asthma Global Evaluation (SAGE): An Electronic Platform for Severe Asthma. Journal of Allergy and Clinical Immunology: In Practice.7(5):1440-9.
  56. Davis SR, Tudball J, Flynn A, Lembke K, Zwar N, Reddel HK.(2019) “You’ve got to breathe, you know” – asthma patients and carers’ perceptions around purchase and use of asthma preventer medicines. Australian and New Zealand Journal of Public Health.43(3):207-13.
  57. DaVeiga SP, Reddel H.(2019) “Everybody’s Got Asthma” – When Misunderstanding and Public Opinion Become Obstacles to the Care of Patients with Severe Asthma. Journal of Allergy and Clinical Immunology: In Practice.
  58. Cordova-Rivera L, Gibson PG, Gardiner PA, McDonald VM.(2019) Physical activity associates with disease characteristics of severe asthma, bronchiectasis and COPD. Respirology.24(4):352-60.
  59. Cordova-Rivera L, Gibson PG, Gardiner PA, Hiles SA, McDonald VM.(2019) Extrapulmonary associations of health status in severe asthma and bronchiectasis: Comorbidities and functional outcomes. Respiratory Medicine.154:93-101.
  60. Cheung MMY, Saini B, Smith L.(2019) ‘It’s a powerful message’: A qualitative study of Australian healthcare professionals’ perceptions of asthma through the medium of drawings. BMJ Open.9(4).
  61. Byrne AL, Marais BJ, Mitnick CD, Garden FL, Lecca L, Contreras C, Yauri Y, Garcia F, Marks GB.(2019) Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru. BMC Pulmonary Medicine.19(1).
  62. Busse WW, Bleecker ER, FitzGerald JM, Ferguson GT, Barker P, Sproule S, Olsson RF, Martin UJ, Goldman M, investigators Bs.(2019) Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial. Lancet Respir Med.7(1):46-59.
  63. Bulathsinhala L, Eleangovan N, Heaney LG, Menzies-Gow A, Gibson PG, Peters M, Hew M, van Boven JFM, Lehtimaki L, van Ganse E, Belhassen M, Harvey ES, Perez de Llano L, Maitland-van der Zee AH, Papadopoulos NG, FitzGerald JM, Porsbjerg C, Canonica GW, Backer V, Rhee CK, Verhamme KMC, Buhl R, Cosio BG, Carter V, Price C, Le T, Stagno d’Alcontres M, Gopalan G, Tran TN, Price D.(2019) Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study. J Allergy Clin Immunol Pract.7(2):578-88 e2.
  64. Bissell K, Ellwood P, Ellwood E, Chiang CY, Marks GB, El Sony A, Asher I, Billo N, Perrin C.(2019) Essential medicines at the national level: The global asthma network’s essential asthma medicines survey 2014. International Journal of Environmental Research and Public Health.16(4).
  65. Beasley R, Holliday M, Reddel HK, Braithwaite I, Ebmeier S, Hancox RJ, Harrison T, Houghton C, Oldfield K, Papi A, Pavord ID, Williams M, Weatherall M.(2019) Controlled trial of budesonide-formoterol as needed for mild asthma. New England Journal of Medicine.380(21):2020-30.
  66. Asher I, Bissell K, Chiang C-Y, El Sony A, Ellwood P, García-Marcos L, Marks GB, Mortimer K, Pearce N, Strachan D.(2019) Calling time on asthma deaths in tropical regions—how much longer must people wait for essential medicines? The Lancet Respiratory Medicine.7(1):13-5.
  67. Aldakheel FM, Bourke JE, Thomas PS, Matheson MC, Abramson MJ, Hamilton GS, Lodge CJ, Thompson BR, Walters EH, Allen KJ, Erbas B, Perret JL, Dharmage SC, Lowe AJ.(2019) NOx in exhaled breath condensate is related to allergic sensitization in young and middle-aged adults. Clin Exp Allergy.49(2):171-9.
2018 Publications
  1. Zimmermann SC, Watts JC, Bertolin A, Jetmalani K, King GG, Thamrin C.(2018) Discrepancy between in vivo and in vitro comparisons of forced oscillation devices. J Clin Monit Comput.32(3):509-12.
  2. Werder RB, Zhang V, Lynch JP, Snape N, Upham JW, Spann K, Phipps S.(2018) Chronic IL-33 expression predisposes to virus-induced asthma exacerbations by increasing type 2 inflammation and dampening antiviral immunity. J Allergy Clin Immunol.141(5):1607-19 e9.
  3. Wark PAB, Ramsahai JM, Pathinayake P, Malik B, Bartlett NW.(2018) Respiratory Viruses and Asthma. Semin Respir Crit Care Med.39(1):45-55.
  4. Wang KCW, Le Cras TD, Larcombe AN, Zosky GR, Elliot JG, James AL, Noble PB.(2018) Independent and combined effects of airway remodelling and allergy on airway responsiveness. Clinical Science.132(3):327-38.
  5. Wang J, Faiz A, Ge Q, Vermeulen CJ, Van der Velden J, Snibson KJ, van de Velde R, Sawant S, Xenaki D, Oliver B, Timens W, Ten Hacken N, van den Berge M, James A, Elliot JG, Dong L, Burgess JK, Ashton AW.(2018) Unique mechanisms of connective tissue growth factor regulation in airway smooth muscle in asthma: Relationship with airway remodelling. J Cell Mol Med.22(5):2826-37.
  6. Upham JW, Chung LP.(2018) Optimising treatment for severe asthma. The Medical journal of Australia.209(2):S22-S7.
  7. Upham JW.(2018) The bronchial epithelial secretory IgA system in asthma. American Journal of Respiratory and Critical Care Medicine.198(9):1236.
  8. Tudball J, Reddel HK, Laba TL, Jan S, Flynn A, Goldman M, Lembke K, Roughead E, Marks GB, Zwar N.(2018) General practitioners’ views on the influence of cost on the prescribing of asthma preventer medicines: a qualitative study. Australian health review : a publication of the Australian Hospital Association.
  9. Toumas-Shehata M, Henricks M, Ovchinikova L, Smith L, Bosnic-Anticevich S.(2018) Teaching Pharmacy Undergraduate Students Inhaler Device Technique and Exploring Factors Affecting Maintenance of Technique. Canadian Respiratory Journal.2018.
  10. Tonga KO, King GG, Farah CS, Thamrin C, Tang FS, Santos J, Sharma P, Chapman DG, Oliver BG.(2018) Steroid insensitive fixed airflow obstruction is not related to airway inflammation in older non-smokers with asthma. Respir Res.19(1):176.
  11. Thien F, Thompson BR.(2018) Precision Medicine in Asthma: Integrating Imaging and Inflammatory Biomarkers. Am J Respir Crit Care Med.197(7):845-6.
  12. Teoh L, Mackay IM, Van Asperen PP, Acworth JP, Hurwitz M, Upham JW, Siew WH, Wang CYT, Sloots TP, Neeman T, Chang AB.(2018) Presence of atopy increases the risk of asthma relapse. Arch Dis Child.103(4):346-51.
  13. Taylor SL, Leong LEX, Choo JM, Wesselingh S, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Baraket M, Marks GB, Gibson PG, Simpson JL, Rogers GB.(2018) Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology. J Allergy Clin Immunol.141(1):94-103 e15.
  14. Revez JA, Killian KJ, O’Byrne PM, Boulet LP, Upham JW, Gauvreau GM, Ferreira MAR.(2018) Sputum cytology during late-phase responses to inhalation challenge with different allergens. Allergy: European Journal of Allergy and Clinical Immunology.
  15. Reid AT, Veerati PC, Gosens R, Bartlett NW, Wark PA, Grainge CL, Stick SM, Kicic A, Moheimani F, Hansbro PM, Knight DA.(2018) Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches. Pharmacol Ther.185:155-69.
  16. Reddel HK, Lembke K, Zwar NJ.(2018) The cost of asthma medicines. Aust Prescr.41(2):34-6.
  17. Reddel HK.(2018) Emerging Concepts in Evidence-Based Asthma Management. Semin Respir Crit Care Med.39(1):82-90.
  18. Ramsahai JM, Simpson J, Wark P.(2018) Eosinophilia as a treatable trait in three patients with asthma and COPD. Respirol Case Rep.6(3):e00295.
  19. Porsbjerg C, Sverrild A, Baines KJ, Searles A, Maltby S, Foster PS, Brightling C, Gibson PG.(2018) Advancing the management of obstructive airways diseases through translational research. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.48(5):493-501.
  20. Pickles K, Eassey D, Reddel HK, Locock L, Kirkpatrick S, Smith L.(2018) “This illness diminishes me. What it does is like theft”: A qualitative meta-synthesis of people’s experiences of living with asthma. Health Expect.21(1):23-40.
  21. Periyalil HA, Wood LG, Wright TA, Karihaloo C, Starkey MR, Miu AS, Baines KJ, Hansbro PM, Gibson PG.(2018) Obese asthmatics are characterized by altered adipose tissue macrophage activation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.48(6):641-9.
  22. Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, Frey U, Gibson P, Heaney LG, Holt PG, Humbert M, Lloyd CM, Marks G, Martinez FD, Sly PD, von Mutius E, Wenzel S, Zar HJ, Bush A.(2018) After asthma: redefining airways diseases. Lancet.391(10118):350-400.
  23. Pathinayake PS, Hsu AC, Waters DW, Hansbro PM, Wood LG, Wark PAB.(2018) Understanding the Unfolded Protein Response in the Pathogenesis of Asthma. Front Immunol.9(FEB):175.
  24. Papi A, Brightling C, Pedersen SE, Reddel HK.(2018) Asthma. The Lancet.391(10122):783-800.
  25. O’Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK.(2018) Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma. New England Journal of Medicine.378(20):1865-76.
  26. Mulrennan S, Knuiman M, Walsh JP, Hui J, Hunter M, Divitini M, Zhu K, Cooke BR, Musk AWB, James A.(2018) Vitamin D and respiratory health in the Busselton Healthy Ageing Study. Respirology.23(6):576-82.
  27. Morten M, Collison A, Murphy VE, Barker D, Oldmeadow C, Attia J, Meredith J, Powell H, Robinson PD, Sly PD, Gibson PG, Mattes J.(2018) Managing Asthma in Pregnancy (MAP) trial: FENO levels and childhood asthma. J Allergy Clin Immunol.142(6):1765-72 e4.
  28. Moheimani F, Koops J, Williams T, Reid AT, Hansbro PM, Wark PA, Knight DA.(2018) Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics. Respir Res.19(1):145.
  29. Menzies-Gow A, Canonica GW, Winders TA, Correia de Sousa J, Upham JW, Fink-Wagner AH.(2018) A Charter to Improve Patient Care in Severe Asthma. Advances in Therapy.35(10):1485-96.
  30. McDonald VM, Yorke J. (2017) Adherence in severe asthma: time to get it right. Eur Respir J.50(6).
  31. McDonald VM, Gibson PG. (2018) The Severe Asthma Toolkit: a new online resource for clinicians. Respiratory Medicine Today.3(1):26-7.
  32. McDonald VM, Maltby S, Gibson PG.(2018) Severe asthma: We can fix it? We can try! Respirology.23(3):260-1.
  33. McDonald VM, Hiles SA, Jones KA, Clark VL, Yorke J.(2018) Health-related quality of life burden in severe asthma. Med J Aust.209(2):S28-S33.
  34. Mateer SW, Mathe A, Bruce J, Liu G, Maltby S, Fricker M, Goggins BJ, Tay HL, Marks E, Burns G, Kim RY, Minahan K, Walker MM, Callister RC, Foster PS, Horvat JC, Hansbro PM, Keely S.(2018) IL-6 Drives Neutrophil-Mediated Pulmonary Inflammation Associated with Bacteremia in Murine Models of Colitis. American Journal of Pathology.188(7):1625-39.
  35. Lynch JP, Werder RB, Loh Z, Sikder MAA, Curren B, Zhang V, Rogers MJ, Lane K, Simpson J, Mazzone SB, Spann K, Hayball J, Diener K, Everard ML, Blyth CC, Forstner C, Dennis PG, Murtaza N, Morrison M, P OC, Zhang P, Haque A, Hill GR, Sly PD, Upham JW, Phipps S.(2018) Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion. J Exp Med.215(2):537-57.
  36. Loymans RJB, Debray TPA, Honkoop PJ, Termeer EH, Snoeck-Stroband JB, Schermer TRJ, Assendelft WJJ, Timp M, Chung KF, Sousa AR, Sont JK, Sterk PJ, Reddel HK, Ter Riet G.(2018) Exacerbations in Adults with Asthma: A Systematic Review and External Validation of Prediction Models. J Allergy Clin Immunol Pract.6(6):1942-52 e15.
  37. Knibbs LD, Woldeyohannes S, Marks GB, Cowie CT.(2018) Damp housing, gas stoves, and the burden of childhood asthma in Australia. Med J Aust.208(7):299-302.
  38. King GG, James A, Harkness L, Wark PAB.(2018) Pathophysiology of severe asthma: We’ve only just started. Respirology.23(3):262-71.
  39. Khatri S, Moore W, Gibson PG, Leigh R, Bourdin A, Maspero J, Barros M, Buhl R, Howarth P, Albers FC, Bradford ES, Gilson M, Price RG, Yancey SW, Ortega H.(2018) Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma. J Allergy Clin Immunol.
  40. Jurak LM, Xi Y, Landgraf M, Carroll ML, Murray L, Upham JW.(2018) Interleukin 33 selectively augments rhinovirus-induced type 2 immune responses in asthmatic but not healthy people. Frontiers in Immunology.9(AUG).
  41. Jensen ME, Murphy VE, Gibson PG, Mattes J, Camargo CA, Jr.(2018) Vitamin D status in pregnant women with asthma and its association with adverse respiratory outcomes during infancy. J Matern Fetal Neonatal Med.1-6.
  42. James AL, Noble PB, Drew SA, Mauad T, Bai TR, Abramson MJ, McKay KO, Green FHY, Elliot JG.(2018) Airway smooth muscle proliferation and inflammation in asthma. Journal of Applied Physiology.125(4):1090-6.
  43. James A, Abramson M.(2018) Fast food and asthma and allergy: Be afried, be deeply afried? Respirology.23(10):881-2.
  44. Hosseini B, Berthon BS, Saedisomeolia A, Starkey MR, Collison A, Wark PAB, Wood LG.(2018) Effects of fruit and vegetable consumption on inflammatory biomarkers and immune cell populations: a systematic literature review and meta-analysis. Am J Clin Nutr.108(1):136-55.
  45. Hiles SA, Harvey ES, McDonald VM, Peters M, Bardin P, Reynolds PN, Upham JW, Baraket M, Bhikoo Z, Bowden J, Brockway B, Chung LP, Cochrane B, Foxley G, Garrett J, Hew M, Jayaram L, Jenkins C, Katelaris C, Katsoulotos G, Koh MS, Kritikos V, Lambert M, Langton D, Lara Rivero A, Marks GB, Middleton PG, Nanguzgambo A, Radhakrishna N, Reddel H, Rimmer J, Southcott AM, Sutherland M, Thien F, Wark PAB, Yang IA, Yap E, Gibson PG.(2018) Working while unwell: Workplace impairment in people with severe asthma. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.48(6):650-62.
  46. Haw TJ, Starkey MR, Pavlidis S, Fricker M, Arthurs AL, Nair PM, Liu G, Hanish I, Kim RY, Foster PS, Horvat JC, Adcock IM, Hansbro PM.(2018) Toll-like receptor 2 and 4 have opposing roles in the pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease. American Journal of Physiology – Lung Cellular and Molecular Physiology.314(2):L298-L317.
  47. Hedman AM, Gong T, Lundholm C, Dahlén E, Ullemar V, Brew BK, Almqvist C.(2018) Agreement between asthma questionnaire and health care register data. Pharmacoepidemiology and Drug Safety.27(10):1139-46.
  48. Godbout K, McDonald VM, Gibson PG. Definitions of Asthma and COPD and overlap syndrome. In: Bernstein JA, Boulet LP, Wechsler ME, editors. Asthma, COPD and the Overlap Syndrome: A cased-based overview of similarities and differences: CRC Press; 2018.
  49. Gibson PG.(2018) Variability of blood eosinophils as a biomarker in asthma and COPD. Respirology.23(1):12-3.
  50. Gibson PG.(2018) How does azithromycin improve asthma exacerbations? – Author’s reply. The Lancet.391(10115):28-9.
  51. Ferreira DS, Kaushik S, Smith CL, Dharmage SC, Benke GP, Thompson BR, Walters EH, Wolfe R, Abramson MJ.(2018) Associations of atopy and asthma during aging of an adult population over a 20-year follow-up. The Journal of asthma : official journal of the Association for the Care of Asthma.55(9):994-1001.
  52. Fanning M, Upham JW.(2018) Reducing the burden of severe asthma. Respiratory Medicine Today.3(2):10-4.
  53. Faiz A, Weckmann M, Tasena H, Vermeulen CJ, Van den Berge M, Ten Hacken NHT, Halayko AJ, Ward JPT, Lee TH, Tjin G, Black JL, Haghi M, Xu CJ, King GG, Farah CS, Oliver BG, Heijink IH, Burgess JK.(2018) Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1beta treatment: a novel role for CCL20 in chronic mucus hypersecretion. The European respiratory journal.52(2).
  54. Elliot JG, Noble PB, Mauad T, Bai TR, Abramson MJ, McKay KO, Green FHY, James AL.(2018) Inflammation-dependent and independent airway remodelling in asthma. Respirology.23(12):1138-45.
  55. Eassey D, Reddel HK, Foster JM, Kirkpatrick S, Locock L, Ryan K, Smith L.(2018) “…I’ve said I wish I was dead, you’d be better off without me”: A systematic review of people’s experiences of living with severe asthma. The Journal of asthma : official journal of the Association for the Care of Asthma.1-12.
  56. Donovan GM, Elliot JG, Green FHY, James AL, Noble PB.(2018) Unraveling a clinical paradox: Why does bronchial thermoplasty work in asthma? American Journal of Respiratory Cell and Molecular Biology.59(3):355-62.
  57. Demenais F, Margaritte-Jeannin P, Barnes KC, Cookson WOC, Altmüller J, Ang W, Barr RG, Beaty TH, Becker AB, Beilby J, Bisgaard H, Bjornsdottir US, Bleecker E, Bønnelykke K, Boomsma DI, Bouzigon E, Brightling CE, Brossard M, Brusselle GG, Burchard E, Burkart KM, Bush A, Chan-Yeung M, Chung KF, Couto Alves A, Curtin JA, Custovic A, Daley D, De Jongste JC, Del-Rio-Navarro BE, Donohue KM, Duijts L, Eng C, Eriksson JG, Farrall M, Fedorova Y, Feenstra B, Ferreira MA, Freidin MB, Gajdos Z, Gauderman J, Gehring U, Geller F, Genuneit J, Gharib SA, Gilliland F, Granell R, Graves PE, Gudbjartsson DF, Haahtela T, Heckbert SR, Heederik D, Heinrich J, Heliövaara M, Henderson J, Himes BE, Hirose H, Hirschhorn JN, Hofman A, Holt P, Hottenga J, Hudson TJ, Hui J, Imboden M, Ivanov V, Jaddoe VWV, James A, Janson C, Jarvelin MR, Jarvis D, Jones G, Jonsdottir I, Jousilahti P, Kabesch M, Kähönen M, Kantor DB, Karunas AS, Khusnutdinova E, Koppelman GH, Kozyrskyj AL, Kreiner E, Kubo M, Kumar R, Kumar A, Kuokkanen M, Lahousse L, Laitinen T, Laprise C, Lathrop M, Lau S, Lee YA, Lehtimäki T, Letort S, Levin AM, Li G, Liang L, Loehr LR, London SJ, Loth DW, Manichaikul A, Marenholz I, Martinez FJ, Matheson MC, Mathias RA, Matsumoto K, Mbarek H, McArdle WL, Melbye M, Melén E, Meyers D, Michel S, Mohamdi H, Musk AW, Myers RA, Nieuwenhuis MAE, Noguchi E, O’Connor GT, Ogorodova LM, Palmer CD, Palotie A, Park JE, Pennell CE, Pershagen G, Polonikov A, Postma DS, Probst-Hensch N, Puzyrev VP, Raby BA, Raitakari OT, Ramasamy A, Rich SS, Robertson CF, Romieu I, Salam MT, Salomaa V, Schlünssen V, Scott R, Selivanova PA, Sigsgaard T, Simpson A, Siroux V, Smith LJ, Solodilova M, Standl M, Stefansson K, Strachan DP, Stricker BH, Takahashi A, Thompson PJ, Thorleifsson G, Thorsteinsdottir U, Tiesler CMT, Torgerson DG, Tsunoda T, Uitterlinden AG, Van Der Valk RJP, Vaysse A, Vedantam S, Von Berg A, Von Mutius E, Vonk JM, Waage J, Wareham NJ, Weiss ST, White WB, Wickman M, Widén E, Willemsen G, Williams LK, Wouters IM, Yang JJ, Zhao JH, Moffatt MF, Ober C, Nicolae DL.(2018) Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nature Genetics.50(1):42-50.
  58. Cordova-Rivera L, Gibson PG, Gardiner PA, Powell H, McDonald VM.(2018) Physical Activity and Exercise Capacity in Severe Asthma: Key Clinical Associations. J Allergy Clin Immunol Pract.6(3):814-22.
  59. Cordova-Rivera L, Gibson PG, Gardiner PA, McDonald VM.(2018) A Systematic Review of Associations of Physical Activity and Sedentary Time with Asthma Outcomes. J Allergy Clin Immunol Pract.6(6):1968-81 e2.
  60. Clifford S, Mazaheri M, Salimi F, Ezz WN, Yeganeh B, Low-Choy S, Walker K, Mengersen K, Marks GB, Morawska L.(2018) Effects of exposure to ambient ultrafine particles on respiratory health and systemic inflammation in children. Environ Int.114:167-80.
  61. Chung LP, Hew M, Bardin P, McDonald VM, Upham JW.(2018) Managing patients with severe asthma in Australia: Current challenges with the existing models of care. Internal medicine journal.48(12):1536-41.
  62. Cheung MMY, Saini B, Smith L.(2018) Patients’ drawings of their asthma: adding qualitative specificity to a quantitative measure of illness perceptions. Journal of Asthma.
  63. Chapman DG, King GG.(2018) Potential clinical utility for the multiple breath nitrogen washout. Respirology.23(8):729-30.
  64. Bowatte G, Lodge CJ, Knibbs LD, Erbas B, Perret JL, Jalaludin B, Morgan GG, Bui DS, Giles GG, Hamilton GS, Wood-Baker R, Thomas P, Thompson BR, Matheson MC, Abramson MJ, Walters EH, Dharmage SC.(2018) Traffic related air pollution and development and persistence of asthma and low lung function. Environ Int.113:170-6.
  65. Bill Musk A, Hunter M, Hui J, Knuiman MW, Divitini M, Beilby JP, James A.(2018) Obstructive airway disease in 46-65-year-old people in busselton, western Australia, 1966-2015. Medical Journal of Australia.208(5):209-13.
  66. Beaurivage D, Boulet LP, Foster JM, Gibson PG, McDonald VM.(2018) Validation of the patient-completed asthma knowledge questionnaire (PAKQ). The Journal of asthma : official journal of the Association for the Care of Asthma.55(2):169-79.
  67. Bateman ED, Reddel HK, O’Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM.(2018) As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma. New England Journal of Medicine.378(20):1877-87.
  68. Bateman ED, Reddel HK, FitzGerald JM.(2018) As-Needed Budesonide-Formoterol in Mild Asthma. The New England journal of medicine.379(9):898.
  69. Basheti IA, Obeidat NM, Reddel HK.(2018) Inhaler technique education and asthma control among patients hospitalized for asthma in Jordan. Saudi Pharmaceutical Journal.26(8):1127-36.
  70. Bacon SL, Gibson PG.(2018) Behavioral Interventions for Asthma: What Kind of Exercise and Diets Should We Be Prescribing? J Allergy Clin Immunol Pract.6(3):812-3.
  71. Aaron SD, Boulet LP, Reddel HK, Gershon AS.(2018) Underdiagnosis and overdiagnosis of asthma. American Journal of Respiratory and Critical Care Medicine.198(8):1012-20.
2017 Publications
  1. Xi Y, Troy NM, Anderson D, Pena OM, Lynch JP, Phipps S, Bosco A, Upham JW.(2017) Critical role of plasmacytoid dendritic cells in regulating gene expression and innate immune responses to human rhinovirus-16. Frontiers in Immunology.8(OCT).
  2. Agustí A, Bafadhel M, Beasley R, Bel EH, Faner R, Gibson PG, Louis R, McDonald VM, Sterk PJ, Thomas M, Vogelmeier C, Pavord ID.(2017) Precision medicine in airway diseases: moving to clinical practice. The European respiratory journal.50(4).
  3. Brew BK, Gong T, Williams DM, Larsson H, Almqvist C.(2017) Using fathers as a negative control exposure to test the Developmental Origins of Health and Disease Hypothesis: A case study on maternal distress and offspring asthma using Swedish register data. Scandinavian Journal of Public Health.45(17_suppl):36-40.
  4. Clark VL, Gibson PG, Genn G, Hiles SA, Pavord ID, McDonald VM.(2017) Multidimensional assessment of severe asthma: A systematic review and meta-analysis. Respirology.22(7):1262-75.
  5. Lindemalm C, Nordlund B, Örtqvist AK, Lundholm C, Van Hage M, Gong T, Almqvist C.(2017) Associations between Asthma and Sensitization to Pet or Pollen Allergens in Young Swedish Twins – The STOPPA Study. Twin Research and Human Genetics.20(5):380-8.
  6. Peters D, Davis S, Calvo RA, Sawyer SM, Smith L, Foster JM.(2017) Young people’s preferences for an asthma self-management app highlight psychological needs: A participatory study. Journal of Medical Internet Research.19(4).
  7. Woodruff PG, Van Den Berge M, Boucher RC, Brightling C, Burchard EG, Christenson SA, Han MK, Holtzman MJ, Kraft M, Lynch DA, Martinez FD, Reddel HK, Sin DD, Washko GR, Wenzel SE, Punturieri A, Freemer MM, Wise RA (2017) American thoracic society/national heart, lung, and blood institute asthma-chronic obstructive pulmonary disease overlap workshop report. American Journal of Respiratory and Critical Care Medicine 196: 375-381.
  8. Wang L, Liang R, Zhou T, Zheng J, Liang BM, Zhang HP, Luo FM, Gibson PG, Wang G (2017) Identification and validation of asthma phenotypes in Chinese population using cluster analysis. Annals of Allergy, Asthma and Immunology 119: 324-332.
  9. Wang G, Wang F, Gibson PG, Guo M, Zhang WJ, Gao P, Zhang HP, Harvey ES, Li H, Zhang J (2017) Severe and uncontrolled asthma in China: A cross-sectional survey from the Australasian Severe Asthma Network. Journal of Thoracic Disease 9: 1333-1344.
  10. Upham JW, Xi Y (2017) Dendritic Cells in Human Lung Disease: Recent Advances. Chest 151: 668-673.
  11. Scott HA, Wood LG, Gibson PG (2017) Role of Obesity in Asthma: Mechanisms and Management Strategies. Current Allergy and Asthma Reports 17.
  12. Rosner SR, Pascoe CD, Blankman E, Jensen CC, Krishnan R, James AL, Elliot JG, Green FH, Liu JC, Seow CY, Park JA, Beckerle MC, Paré PD, Fredberg JJ, Smith MA (2017) The actin regulator zyxin reinforces airway smooth muscle and accumulates in airways of fatal asthmatics. PloS one 12: e0171728.
  13. Robinson PD, King GG, Sears MR, Hong CY, Hancox RJ (2017) Determinants of peripheral airway function in adults with and without asthma. Respirology 22: 1110-1117.
  14. Reddel HK, Valenti L, Easton KL, Gordon J, Bayram C, Miller GC (2017) Assessment and management of asthma and chronic obstructive pulmonary disease in Australian general practice. Australian Family Physician 46: 413-419.
  15. Reddel HK, Busse WW, Pedersen S, Tan WC, Chen YZ, Jorup C, Lythgoe D, O’Byrne PM (2017) Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study. The Lancet 389: 157-166.
  16. Reddel HK, Beckert L, Moran A, Ingham T, Ampon RD, Peters MJ, Sawyer SM (2017) Is higher population-level use of ICS/LABA combination associated with better asthma outcomes? Cross-sectional surveys of nationally representative populations in New Zealand and Australia. Respirology 22: 1570-1578.
  17. Reddel HK, Ampon RD, Sawyer SM, Peters MJ (2017) Risks associated with managing asthma without a preventer: Urgent healthcare, poor asthma control and over-the-counter reliever use in a cross-sectional population survey. BMJ Open 7.
  18. Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, Frey U, Gibson P, Heaney LG, Holt PG, Humbert M, Lloyd CM, Marks G, Martinez FD, Sly PD, von Mutius E, Wenzel S, Zar HJ, Bush A (2017) After asthma: Redefining airways diseases. The Lancet.
  19. Papi A, Brightling C, Pedersen SE, Reddel HK (2017) Asthma. The Lancet.
  20. O’Byrne PM, FitzGerald JM, Zhong N, Bateman E, Barnes PJ, Keen C, Almqvist G, Pemberton K, Jorup C, Ivanov S, Reddel HK (2017) The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: Study protocols for two randomised controlled trials. Trials 18.
  21. Murphy VE, Jensen ME, Powell H, Gibson PG (2017) Influence of Maternal Body Mass Index and Macrophage Activation on Asthma Exacerbations in Pregnancy. Journal of Allergy and Clinical Immunology: In Practice 5: 981-987.e981.
  22. Murphy VE, Jensen ME, Gibson PG (2017) Asthma during Pregnancy: Exacerbations, Management, and Health Outcomes for Mother and Infant. Seminars in Respiratory and Critical Care Medicine 38: 160-173.
  23. Jenkins CR, Eriksson G, Bateman ED, Reddel HK, Sears MR, Lindberg M, O’Byrne PM (2017) Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment. BMC Pulmonary Medicine 17.
  24. James A (2017) Airway remodeling in asthma: Is it fixed or variable? American Journal of Respiratory and Critical Care Medicine 195: 968-970.
  25. Israel E, Reddel HK (2017) Severe and difficult-to-treat asthma in adults. New England Journal of Medicine 377: 965-976.
  26. Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Powell H, Taylor SL, Leong LEX, Rogers GB, Simpson JL (2017) Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. The Lancet 390: 659-668.
  27. Fricker M, Gibson PG (2017) Macrophage dysfunction in the pathogenesis and treatment of asthma. European Respiratory Journal 50.
  28. Foster JM, Reddel HK, Usherwood T, Sawyer SM, Smith L (2017) Patient-perceived acceptability and behaviour change benefits of inhaler reminders and adherence feedback: A qualitative study. Respiratory Medicine 129: 39-45.
  29. Foster JM, McDonald VM, Guo M, Reddel HK (2017) “i have lost in every facet of my life”: The hidden burden of severe asthma. European Respiratory Journal 50.
  30. Fingleton J, Hardy J, Baggott C, Pilcher J, Corin A, Hancox RJ, Harwood M, Holliday M, Reddel HK, Shirtcliffe P, Snively S, Weatherall M, Beasley R (2017) Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma. BMJ Open Respir Res 4: e000217.
  31. Farrow CE, Salome CM, Harris BE, Bailey DL, Berend N, King GG (2017) Peripheral ventilation heterogeneity determines the extent of bronchoconstriction in asthma. Journal of Applied Physiology 123: 1188-1194.
  32. Ellwood P, Asher MI, Billo NE, Bissell K, Chiang CY, Ellwood EM, El-Sony A, García-Marcos L, Mallol J, Marks GB, Pearce NE, Strachan DP (2017) The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors. European Respiratory Journal 49.
  33. Basheti IA, Obeidat NM, Reddel HK (2017) Effect of novel inhaler technique reminder labels on the retention of inhaler technique skills in asthma: A single-blind randomized controlled trial. npj Primary Care Respiratory Medicine 27.
  34. McDonald VM, Gibson PG (2017) “to define is to limit”: Perspectives on asthma – COPD overlap syndrome and personalised medicine. European Respiratory Journal 49.
  35. Lau EMT, Roche NA, Reddel HK (2017) Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap. Expert Review of Clinical Immunology 13: 449-455.
  36. Hosseini B, Berthon BS, Wark P, Wood LG (2017) Effects of fruit and vegetable consumption on risk of asthma, wheezing and immune responses: A systematic review and meta-analysis. Nutrients 9.
  37. Halnes I, Baines KJ, Berthon BS, MacDonald-Wicks LK, Gibson PG, Wood LG (2017) Soluble fibre meal challenge reduces airway inflammation and expression of GPR43 and GPR41 in asthma. Nutrients 9.
  38. Gibson PG, McDonald VM. (2017) Management of severe asthma: targeting the airways, comorbidities and risk factors. Internal Medicine Journal.47(6):623-31.
  39. Gibson PG, Peters MJ, Wainwright CE (2017) Targeted therapy for chronic respiratory disease: a new paradigm. The Medical journal of Australia 206: 136-140.
  40. Fricker M, Heaney LG, Upham JW (2017) Can biomarkers help us hit targets in difficult-to-treat asthma? Respirology 22: 430-442.
  41. Ferreira MAR, Jansen R, Willemsen G, Penninx B, Bain LM, Vicente CT, Revez JA, Matheson MC, Hui J, Tung JY, Baltic S, Le Souëf P, Montgomery GW, Martin NG, Robertson CF, James A, Thompson PJ, Boomsma DI, Hopper JL, Hinds DA, Werder RB, Phipps S (2017) Gene-based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling. Journal of Allergy and Clinical Immunology 139: 1148-1157.
  42. Bowatte G, Lodge CJ, Knibbs LD, Lowe AJ, Erbas B, Dennekamp M, Marks GB, Giles G, Morrison S, Thompson B, Thomas PS, Hui J, Perret JL, Abramson MJ, Walters H, Matheson MC, Dharmage SC (2017) Traffic-related air pollution exposure is associated with allergic sensitization, asthma, and poor lung function in middle age. Journal of Allergy and Clinical Immunology 139: 122-129.e121.
  43. Baines KJ, Fu JJ, McDonald VM, Gibson PG (2017) Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease. International Journal of COPD 12: 541-550.
  44. Arikkatt J, Ullah MA, Short KR, Zhang V, Gan WJ, Loh Z, Werder RB, Simpson J, Sly PD, Mazzone SB, Spann KM, Ferreira MAR, Upham JW, Sukkar MB, Phipps S (2017) RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthma. eLife 6.
  45. Murray LA, Grainge C, Wark PA, Knight DA (2017) Use of biologics to treat acute exacerbations and manage disease in asthma, COPD and IPF. Pharmacol Ther 169: 1-12.
  46. McDonald VM, Maltby S, Reddel HK, King GG, Wark PA, Smith L, Upham JW, James AL, Marks GB, Gibson PG (2017) Severe asthma: Current management, targeted therapies and future directions-A roundtable report. Respirology 22: 53-60.
  47. McDonald VM, Maltby S, Gibson PG (2017) Severe asthma: Can we fix it? Prologue to seeking innovative solutions for severe asthma. Respirology 22: 19-20.
  48. Maltby S, Gibson PG, Powell H, McDonald VM (2017) Omalizumab treatment response in a population with severe allergic asthma and overlapping COPD. Chest 151: 78-89.
2016 Publications
  1. Wright TK, Gibson PG, Simpson JL, McDonald VM, Wood LG, Baines KJ (2016) Neutrophil extracellular traps are associated with inflammation in chronic airway disease. Respirology 21: 467-475.
  2. Wark PAB, Hew M, Maltby S, McDonald VM, Gibson PG (2016) Diagnosis and investigation in the severe asthma clinic. Expert Review of Respiratory Medicine 10: 491-503.
  3. Wark P, Frith P (2016) Asthma, COPD and when they coexist. Medicine Today 17: 16-24.
  4. Wang G, Baines KJ, Fu JJ, Wood LG, Simpson JL, McDonald VM, Cowan DC, Taylor DR, Cowan JO, Gibson PG (2016) Sputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma. European Respiratory Journal 47: 1123-1133.
  5. Upham JW, Sly PD (2016) Vitamin D in asthma: Is the golden bullet losing its luster? American Journal of Respiratory and Critical Care Medicine 193: 598-600.
  6. Tay H, Wark PAB, Bartlett NW (2016) Advances in the treatment of virus-induced asthma. Expert Review of Respiratory Medicine 10: 629-641.
  7. Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, Leung JM, Nakano Y, Park HY, Wark PA, Wechsler ME (2016) What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J 48: 664-673.
  8. Simpson JL, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Jia G, Holweg CT, Gibson PG (2016) Periostin levels and eosinophilic inflammation in poorly-controlled asthma. BMC Pulm Med 16: 67.
  9. Simpson JL, Daly J, Baines KJ, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Hugenholtz P, Willner D, Gibson PG (2016) Airway dysbiosis: Haemophilus influenza and Tropheryma in poorly controlled asthma. European Respiratory Journal 47: 792-800.
  10. Simpson JL, Carroll M, Yang IA, Reynolds PN, Hodge S, James AL, Gibson PG, Upham JW.(2016) Reduced Antiviral Interferon Production in Poorly Controlled Asthma Is Associated With Neutrophilic Inflammation and High-Dose Inhaled Corticosteroids. Chest.149(3):704-13.
  11. Scott HA, Gibson PG, Garg ML, Upham JW, Wood LG (2016) Sex hormones and systemic inflammation are modulators of the obese-asthma phenotype. Allergy: European Journal of Allergy and Clinical Immunology 71: 1037-1047.
  12. Sarnowski C, Sugier PE, Granell R, Jarvis D, Dizier MH, Ege M, Imboden M, Laprise C, Khusnutdinova EK, Freidin MB, Cookson WOC, Moffatt M, Lathrop M, Siroux V, Ogorodova LM, Karunas AS, James A, Probst-Hensch NM, von Mutius E, Pin I, Kogevinas M, Henderson AJ, Demenais F, Bouzigon E (2016) Identification of a new locus at 16q12 associated with time to asthma onset. Journal of Allergy and Clinical Immunology.
  13. Revez JA, Matheson MC, Hui J, Baltic S, James A, Upham JW, Dharmage S, Thompson PJ, Martin NG, Hopper JL, Ferreira MAR (2016) Identification of STOML2 as a putative novel asthma risk gene associated with IL6R. Allergy: European Journal of Allergy and Clinical Immunology 71: 1020-1030.
  14. Pilcher J, Patel M, Reddel HK, Pritchard A, Black P, Shaw D, Holt S, Weatherall M, Beasley R (2016) Effect of smoking status on the efficacy of the SMART regimen in high risk asthma. Respirology 21: 858-866.
  15. Moheimani F, Hsu AC, Reid AT, Williams T, Kicic A, Stick SM, Hansbro PM, Wark PA, Knight DA (2016) The genetic and epigenetic landscapes of the epithelium in asthma. Respir Res 17: 119.
  16. Maltby S, Gibson PG, Mattes J, McDonald VM (2016) How to Treat Severe Asthma: Part 1: Diagnosis. Australian Doctor.
  17. Maltby S, Gibson PG, Mattes J, McDonald VM (2016) How to Treat Severe Asthma: Part 2: Management. Australian Doctor.
  18. Lynch JP, Werder RB, Simpson J, Loh Z, Zhang V, Haque A, Spann K, Sly PD, Mazzone SB, Upham JW, Phipps S (2016) Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. Journal of Allergy and Clinical Immunology.
  19. Loymans RJB, Honkoop PJ, Termeer EH, Snoeck-Stroband JB, Assendelft WJJ, Schermer TRJ, Chung KF, Sousa AR, Sterk PJ, Reddel HK, Sont JK, Ter Riet G (2016) Identifying patients at risk for severe exacerbations of asthma: Development and external validation of a multivariable prediction model. Thorax 71: 838-846.
  20. Li Q, Baines KJ, Gibson PG, Wood LG (2016) Changes in Expression of Genes Regulating Airway Inflammation Following a High-Fat Mixed Meal in Asthmatics. Nutrients 8.
  21. Kunarajah K, Pena O, Upham JW.(2016) Understanding the Immune and Inflammatory Response to Rhinoviruses: Recent Advances with Relevance to Asthma. Current Respiratory Medicine Reviews.12(3):215-24.
  22. King GG, Thamrin C (2016) Complex lung function in severe asthma: Seeing is believing. European Respiratory Journal 48: 294-296.
  23. Johnson M, Carlo B, Currow D, Maddocks M, McDonald VM, Mahadeva R, Mason M. Management of chronic breathlessness. Palliative Care in Respiratory Disease: European Respiratory Society; 2016. p. 153-71.
  24. Hodge S, Hodge G, Simpson JL, Yang IA, Upham J, James A, Gibson PG, Reynolds PN, Group ASR (2016) Blood cytotoxic/inflammatory mediators in non-eosinophilic asthma. Clin Exp Allergy 46: 60-70.
  25. Hew M, Gillman A, Sutherland M, Wark P, Bowden J, Guo M, Reddel HK, Jenkins C, Marks GB, Thien F, Rimmer J, Katsoulotos GP, Cook M, Yang I, Katelaris C, Bowler S, Langton D, Wright C, Bint M, Yozghatlian V, Burgess S, Sivakumaran P, Yan KY, Kritikos V, Peters M, Baraket M, Aminazad A, Robinson P, Jaffe A, Powell H, Upham JW, McDonald VM, Gibson PG (2016) Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria. Clin Exp Allergy 46: 1407-1415.
  26. Grainge CL, Maltby S, Gibson PG, Wark PAB, McDonald VM (2016) Targeted therapeutics for severe refractory asthma: Monoclonal antibodies. Expert Review of Clinical Pharmacology 9: 927-941.
  27. Gibson PG, Reddel H, McDonald VM, Marks G, Jenkins C, Gillman A, Upham J, Sutherland M, Rimmer J, Thien F, Katsoulotos GP, Cook M, Yang I, Katelaris C, Bowler S, Langton D, Robinson P, Wright C, Yozghatlian V, Burgess S, Sivakumaran P, Jaffe A, Bowden J, Wark PA, Yan KY, Kritikos V, Peters M, Hew M, Aminazad A, Bint M, Guo M (2016) Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry. Intern Med J 46: 1054-1062.
  28. Gibson PG, McDonald VM (2016) Phenotyping Asthma and COPD. Barcelona Respiratory Network Reviews 2: 239-252.
  29. Foster JM, Smith L, Usherwood T, Sawyer SM, Reddel HK (2016) General practitioner-delivered adherence counseling in asthma: Feasibility and usefulness of skills, training and support tools. Journal of Asthma 53: 311-320.
  30. Blake TL, Chang AB, Petsky HL, Rodwell LT, Brown MG, Hill DC, Thompson B, McElrea MS (2016) Spirometry reference values in Indigenous Australians: a systematic review. Med J Aust 205: 35-40.
  31. Basheti IA, Obeidat NM, Ammari WG, Reddel HK (2016) Associations between inhaler technique and asthma control among asthma patients using pressurised MDIs and DPIs. International Journal of Tuberculosis and Lung Disease 20: 689-695.
  32. Basheti IA, Hamadi SA, Reddel HK (2016) Inter-professional education unveiling significant association between asthma knowledge and inhaler technique. Pharmacy Practice 14.
  33. Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, Humbert M, Jones P, Gibson PG, Vestbo J, Beasley R, Pavord ID (2016) Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J 47: 410-419.
2015 Publications
  1. Wark PAB, McDonald VM, Gibson PG (2015) Adjusting prednisone using blood eosinophils reduces exacerbations and improves asthma control in difficult patients with asthma. Respirology 20: 1282-1284.
  2. Vos T, …… Marks GB, et al. (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet 386: 743-800.
  3. Scott HA, Latham JR, Callister R, Pretto JJ, Baines K, Saltos N, Upham JW, Wood LG.(2015) Acute exercise is associated with reduced exhaled nitric oxide in physically inactive adults with asthma. Annals of Allergy, Asthma and Immunology.114(6):470-9.
  4. Reddel HK, Sawyer SM, Everett PW, Flood PV, Peters MJ (2015) Asthma control in Australia: A cross-sectional web-based survey in a nationally representative population. Medical Journal of Australia 202: 492-498.
  5. Reddel HK, Levy ML (2015) The GINA asthma strategy report: What’s new for primary care? npj Primary Care Respiratory Medicine 25.
  6. Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz AA, Drazen JM, Haahtela T, Hurd SS, Inoue H, De Jongste JC, Lemanske RF, Jr., Levy ML, O’Byrne PM, Paggiaro P, Pedersen SE, Pizzichini E, Soto-Quiroz M, Szefler SJ, Wong GWK, FitzGerald JM (2015) A summary of the new GINA strategy: A roadmap to asthma control. European Respiratory Journal 46: 622-639.
  7. Naik-Panvelkar P, Saini B, LeMay KS, Emmerton LM, Stewart K, Burton DL, Bosnic-Anticevich SZ, Krass I, Smith LD, Armour CL (2015) A pharmacy asthma service achieves a change in patient responses from increased awareness to taking responsibility for their asthma. International Journal of Pharmacy Practice 23: 182-191.
  8. Naghavi M, ……. Marks GB, et al. (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet 385: 117-171.
  9. Lemay KS, Saini B, Bosnic-Anticevich S, Smith L, Stewart K, Emmerton L, Burton DL, Krass I, Armour CL (2015) An exploration of clinical interventions provided by pharmacists within a complex asthma service. Pharmacy Practice 13.
  10. Lei Burton D, LeMay KS, Saini B, Smith L, Bosnic-Anticevich S, Southwell P, Cooke J, Emmerton L, Stewart K, Krass I, Reddel H, Armour C (2015) The reliability and utility of spirometry performed on people with asthma in community pharmacies. Journal of Asthma 52: 913-919.
  11. Harris KM, Kneale D, Lasserson TJ, McDonald VM, Grigg J, Thomas J.(2015) School‐based self management interventions for asthma in children and adolescents: a mixed methods systematic review. Cochrane Database of Systematic Reviews. (4).
  12. Hatchwell L, Collison A, Girkin J, Parsons K, Li J, Zhang J, Phipps S, Knight D, Bartlett NW, Johnston SL, Foster PS, Wark PAB, Mattes J (2015) Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax 70: 854-861.
  13. Gibson PG, McDonald VM.(2015) Asthma-COPD overlap 2015: Now we are six. Thorax.70(7):683-91.
  14. Gao P, Gibson PG, Baines KJ, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Zhang J, Simpson JL (2015) Anti-inflammatory deficiencies in neutrophilic asthma: Reduced galectin-3 and IL-1RA/IL-1β. Respiratory Research 16.
  15. Fu JJ, McDonald VM, Baines KJ, Gibson PG.(2015) Airway IL-1β and systemic inflammation as predictors of future exacerbation risk in asthma and COPD. Chest.148(3):618-29.
  16. Forouzanfar MH……. Marks GB et al. (2015) Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet 386: 2287-2323.
  17. Farah CS, Keulers LAB, Hardaker KM, Peters MJ, Berend N, Postma DS, Salome CM, King GG (2015) Association between peripheral airway function and neutrophilic inflammation in asthma. Respirology 20: 975-981.
  18. Elliot JG, Jones RL, Abramson MJ, Green FH, Mauad T, McKay KO, Bai TR, James AL (2015) Distribution of airway smooth muscle remodelling in asthma: Relation to airway inflammation. Respirology 20: 66-72.
  19. Elliot JG, Budgeon CA, Harji S, Jones RL, James AL, Green FH (2015) The effect of asthma on the perimeter of the airway basement membrane. Journal of Applied Physiology 119: 1114-1117.
  20. Dame Carroll JR, Magnussen JS, Berend N, Salome CM, King GG (2015) Greater parallel heterogeneity of airway narrowing and airway closure in asthma measured by high-resolution CT. Thorax 70: 1163-1170.
  21. Cooksley NAJB, Atkinson D, Marks GB, Toelle BG, Reeve D, Johns DP, Abramson MJ, Burton DL, James AL, Wood-Baker R, Walters EH, Buist AS, Maguire GP (2015) Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study. Respirology 20: 766-774.
  22. Bateman ED, Buhl R, O’Byrne PM, Humbert M, Reddel HK, Sears MR, Jenkins C, Harrison TW, Quirce S, Peterson S, Eriksson G (2015) Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations. Journal of Allergy and Clinical Immunology 135: 1457-1464e1454.
  23. Baines KJ, Wright TK, Simpson JL, McDonald VM, Wood LG, Parsons KS, Wark PA, Gibson PG (2015) Airway β -Defensin-1 Protein Is Elevated in COPD and Severe Asthma. Mediators of Inflammation 2015.
  24. Baines KJ, Backer V, Gibson PG, Powell H, Porsbjerg CM (2015) Impaired lung function is associated with systemic inflammation and macrophage activation. Eur Respir J 45: 557-559.

Chief Investigators are indicated in bold. Associate investigators and funded staff and trainees are underlined.

Join Our Mailing List

Funded By

Twitter Feed

Contact us

Postal Address
NHMRC Centre of Excellence in Severe Asthma
c/o Hunter Medical Research Institute
Locked Bag 1000
New Lambton, NSW 2305
AUSTRALIA
Copyright 2016    CRICOS Provider Number 00109J    The University of Newcastle, Australia